KBC Group
EVH icon

KBC Group’s Evolent Health EVH Stock Holding History

KBC Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,741
Closed -$64K – 1745
2025
Q1 		$64K Hold
6,741
– – ﹤0.01% 1713
2024
Q4 		$76K Buy
6,741
+3,739
+125% +$65.7K ﹤0.01% 1697
2024
Q3 		$85K Hold
3,002
– – ﹤0.01% 1392
2024
Q2 		$57K Buy
3,002
+694
+30% +$17.7K ﹤0.01% 1540
2024
Q1 		$76K Hold
2,308
– – ﹤0.01% 1277
2023
Q4 		$76K Hold
2,308
– – ﹤0.01% 1232
2023
Q3 		$63K Buy
+2,308
New +$64.2K ﹤0.01% 1265

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

KBC Group's EVH Position: Q2 2025 in Review

KBC Group sold out of Evolent Health (EVH) in Q2 2025, closing a stake of 6,741 shares — an estimated $64K sold.

KBC Group first reported a position in EVH in Q3 2023 and held it in 7 quarters. The position peaked at $85K in Q3 2024. 220 funds tracked by Wall St. Rank hold EVH as of Q2 2025.

  • KBC Group reported no remaining Evolent Health position as of Q2 2025 after selling out during the quarter.
  • KBC Group sold 6,741 Evolent Health shares in Q2 2025, an estimated $64K.
  • KBC Group first reported a position in Evolent Health in Q3 2023 and held it in 7 quarters.
  • KBC Group's Evolent Health position peaked at $85K in Q3 2024.
  • 220 funds tracked by Wall St. Rank held Evolent Health as of Q2 2025.

Based on KBC Group's 13F filing for Q2 2025, filed 8 Aug 2025.